Chitosan Shell Microcapsules for Lipid Oxidation Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Krill and fish oils face challenges due to their oxidative instability and unpleasant taste and odor, which affect their use in food and supplements, leading to quality issues and consumer acceptance.

Innovation Solution

The development of core-shell microcapsules with a lipid emulsion core containing denatured or hydrolysed protein and carbohydrate, stabilized by a chitosan shell, which inhibits oxidation and masks odors, ensuring gastric transit and digestion while maintaining stability during storage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If PUFA's are directly added into food products and supplements, then the health benefits are provided, but oxidative stress and rancidity occur reducing shelf life

Engineering Contradiction:
Improvestability of PUFA'sVSAvoidshelf life
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent segments the PUFA's from the food matrix by encapsulating them within microcapsules. The lipid core containing PUFA's is separated from the external environment by a protective hydrocolloid wall, preventing direct contact with oxygen and other degrading factors while maintaining the health benefits of the fatty acids.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs a flexible hydrocolloid wall (thin film) that encapsulates the lipid core containing PUFA's. This wall acts as a barrier against oxidation and rancidity, protecting the sensitive fatty acids while allowing the microcapsule to remain stable during storage and processing.

Inventive Principle:
Principle #30Flexible shells and thin films

2Ease of operation

If krill oil is used as nutritional supplement, then rapid absorption is achieved, but oxidative instability and unpleasant taste and odor occur

Engineering Contradiction:
Improveabsorption rateVSAvoidoxidative instability and odor
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent uses a flexible hydrocolloid wall to encapsulate the krill oil lipid core, creating a protective barrier that prevents oxidative instability and masks unpleasant taste and odor. The wall acts as a shield against environmental factors while allowing the krill oil to maintain its rapid absorption properties.

Inventive Principle:
Principle #30Flexible shells and thin films

Solution Approach 2:

The hydrocolloid wall creates an inert protective environment around the krill oil, isolating it from oxygen and other factors that cause oxidation and unpleasant odors. This protective atmosphere allows the krill oil to remain stable while preserving its bioavailability.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

3Reliability

If encapsulation techniques are used, then degradation is inhibited and quality is preserved, but device complexity increases

Engineering Contradiction:
Improvequality preservationVSAvoidencapsulation structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs a relatively simple hydrocolloid wall structure that provides effective protection against degradation. While this adds some complexity compared to direct addition, the wall structure is straightforward and can be produced using conventional microencapsulation techniques, balancing protection with manufacturability.

Inventive Principle:
Principle #30Flexible shells and thin films

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The microencapsulation process significantly enhances the stability and palatability of polyunsaturated fatty acids, reducing oxidative stress and extending shelf life, making them suitable for broader product applications.

Implementation Method 1

a crosslinked hydrocolloid matrix consisting of protein and chitin origin

Methodology Applied
Scientific EffectOxidation inhibition: Oxidation

Implementation Method 2

method of producing micro-capsules by double extrusion

Methodology Applied
Scientific EffectExtrusion: Extrusion

Implementation Method 3

gelated mono-nuclear microencapsulates comprising a lipid emulsion core encapsulated within a gelated membrane shell

Methodology Applied
Scientific EffectGelation: Gel

Data Source

PatentEP3302105B1Microencapsulates containing stabilised lipid, and methods for the production thereof
Publication Date: 2021.01.27 ANABIO TECH LTD
  • EP3302105B1 patent drawingFigure 1
  • EP3302105B1 patent drawingFigure 2
  • EP3302105B1 patent drawingFigure 3

AI summary

The invention provides a gelated mono-nuclear microencapsulate comprising a lipid emulsion core encapsulated within a gastro-resistant, ileal sensitive, polymerized chitosan membrane shell, wherein the lipid emulsion core comprises denatured or hydrolysed protein and carbohydrate. In one embodiment of the invention, the emulsion is a micro-emulsion, and typically comprises a surfactant and a co-surfactant or at least two carbohydrates, for example sucrose and a maltodextrin. In one embodiment of the invention, the lipid is a marine derived lipid such as fish oil, krill oil, or nutraceutical fatty acids. In other embodiment, the lipid is a fatty acid such as DHA or ARA, or a lipid derived from seeds, nuts or eggs.